Esomeprazole 20 mg + Placebo

ApprovedCompleted

0 watching 0 views this week🔥 Hot

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

✓

Phase 3

Approved

Indication / Disease

Heartburn

Conditions

Heartburn

Trial Timeline

Jan 1, 2016 → Apr 1, 2016

NCT ID

NCT02708355

About Esomeprazole 20 mg + Placebo

Esomeprazole 20 mg + Placebo is a approved stage product being developed by Pfizer for Heartburn. The current trial status is completed. This product is registered under clinical trial identifier NCT02708355. Target conditions include Heartburn.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT02708355	Approved	Completed	Jan 1, 2016	Apr 1, 2016	Heartburn

Competing Products

20 competing products in Heartburn

See all competitors

Product	Company	Stage	Hype Score
rabeprazole sodium	Eisai	Phase 3	77
rabeprazole sodium + placebo	Eisai	Phase 3	77
Rabeprazole sodium	Eisai	Pre-clinical	23
famotidine (+) calcium carbonate (+) magnesium hydroxide tablet + Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet without water + Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet with water	Johnson & Johnson	Phase 1	33
esomeprazole 40 mg	AstraZeneca	Approved	85
Esomeprazole magnesium (Nexium)	AstraZeneca	Approved	85
Esomeprazole	AstraZeneca	Phase 3	77
Esomeprazole	AstraZeneca	Phase 3	77
Esomeprazole + Lansoprazole + Pantoprazole	AstraZeneca	Approved	85
Esomeprazole Magnesium + Lansoprazole	AstraZeneca	Approved	85
Famotidine FCT + Famotidine CT	Merck	Phase 1	33
Lanzoprazole	Novartis	Phase 3	77
Lansoprazole + Lansoprazole + placebo	Novartis	Phase 3	77
Lansoprazole	Novartis	Phase 3	77
Tegaserod	Novartis	Phase 3	77
Calcium carbonate/magnesium hydroxide/Lansoprazole 15 mg + Lansoprazole + Calcium carbonate/magnesium hydroxide + Placebo	Novartis	Phase 2	52
bi-layer calcium carbonate tablet (BAY1180654) + Immediate release calcium carbonate tablet (BAY1180654)	Bayer	Phase 1	30
omeprazole/sodium bicarbonate + omeprazole magnesium	Bayer	Phase 1	30
Talcid (Hydrotalcite, BAY4516H) + Famotidine + Placebo	Bayer	Approved	82
Omeprazole 20 mg + Sodium Bicarbonate 1100 mg + Omeprazole 20 mg	Bayer	Approved	82

Other Products from Pfizer